| 1 | CRSP | CRISPR Therapeutics AG | 5.42% |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.08% |
| 3 | ILMN | Illumina, Inc. | 4.86% |
| 4 | LEGN | Legend Biotech Corporation | 4.65% |
| 5 | MRNA | Moderna, Inc. | 4.60% |
| 6 | QGEN | Qiagen N.V. | 4.32% |
| 7 | RNA | Avidity Biosciences, Inc. | 4.20% |
| 8 | TECH | Bio-Techne Corporation | 4.02% |
| 9 | GH | Guardant Health, Inc. | 3.92% |
| 10 | BNTX | BioNTech SE | 3.66% |
| 11 | NTRA | Natera, Inc. | 3.66% |
| 12 | BMRN | BioMarin Pharmaceutical Inc. | 3.57% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 3.56% |
| 14 | HKG: 1548 | Genscript Biotech Corporation | 2.92% |
| 15 | RARE | Ultragenyx Pharmaceutical Inc. | 2.78% |
| 16 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.67% |
| 17 | TWST | Twist Bioscience Corporation | 2.51% |
| 18 | WGS | GeneDx Holdings Corp. | 2.48% |
| 19 | VCYT | Veracyte, Inc. | 2.31% |
| 20 | BEAM | Beam Therapeutics Inc. | 2.18% |
| 21 | A | Agilent Technologies, Inc. | 2.10% |
| 22 | GILD | Gilead Sciences, Inc. | 1.94% |
| 23 | LON: AZN | AstraZeneca PLC | 1.90% |
| 24 | BMY | Bristol-Myers Squibb Company | 1.87% |
| 25 | LLY | Eli Lilly and Company | 1.74% |
| View GNOM holdings |
